Advertisement

Receptor Biology Incorporated Company Profile

12:11 EDT 24th May 2013 | BioPortfolio

Receptor Biology Inc. produce cloned receptors for pharmacology studies and drug discovery, products include adenosine, cannabinoid, dopamine, muscarinic, serotonin, opoid, bradykinin, transporter, wild type.

Location

10,000 Virginia Manor Road, Suite 360
Beltsville
MD
20705
United States of America

Contact

Phone: 301 210 4700


News Articles [ 849 Associated News Articles listed on BioPortfolio]

Synthetic derivatives of THC may weaken HIV-1 infection to enhance antiviral therapies

(Federation of American Societies for Experimental Biology) A new research report published in the Journal of Leukocyte Biology shows that compounds that stimulate the cannabinoid type 2 receptor in w...

Compounds That Stimulate The Cannabinoid Type 2 Receptor In White Blood Cells Can Weaken HIV-1 Infection

A new use for compounds related in composition to the active ingredient in marijuana may be on the horizon: a new research report published in the Journal of Leukocyte Biology shows that compounds tha...

Evolutionary biology: Researchers solve toll-receptor puzzle

The puzzle about the ancestral function of toll-receptors has been solved. For more than 25 years, researchers from medicine and biology have been studying toll-receptors, revealing functions in immun...

[Comment] IGF-1R inhibition: right direction, wrong pathway?

Inhibition of oestrogen receptor is a mainstay of treatment for oestrogen-receptor-positive breast cancer. Unfortunately, intrinsic and acquired resistance undermine the long-term effectiveness of end...

Specifit Receptor Sparks Prostate Cancer Progression

Prostate cancer presents a dilemma for patients and the physicians who treat them. Which cancers are essentially indolent and present no risk and which are life threatening? Which can be watched and w...

NovAliX and Inventiva form drug discovery alliance based on nuclear receptors

Inventiva and NovAliX have entered into a strategic alliance dedicated to the discovery of clinical candidates targeting nuclear receptors. Having collaborated in the field of nuclear receptors and wi...

Evidence for the existence of dopamine d2-oxytocin receptor heteromers in the ventral and dorsal striatum with facilitatory receptor–receptor interactions

How insulin engages its primary binding site on the insulin receptor

Insulin receptor signalling has a central role in mammalian biology, regulating cellular metabolism, growth, division, differentiation and survival. Insulin resistance contributes to the pathogenesis...

PubMed Articles [ 355 Associated PubMed Articles listed on BioPortfolio]

In Silico Characterization of Ligand Binding Modes in the Human Histamine H(4) Receptor and their Impact on Receptor Activation.

The dopamine D(4) receptor, the ultimate disordered protein.

The human D4 dopamine receptor is a synaptic neurotransmitter receptor responsible for neuronal signaling in the mesolimbic system of the brain, an area of the brain that regulates emotion and complex...

Structural Biology by Mass Spectrometry: Mapping Protein Interaction Surfaces of Membrane Receptor Complexes with ICAT.

Bax is Essential for Death Receptor-Mediated Apoptosis in Human Colon Cancer Cells.

Abstract To demonstrate the role of Bax in death receptor-induced apoptosis in the human colon cancer HCT116 cells. We treated HCT116 cells and HCT116 with p53(-/-) (KO) by 0.1 μg/mL TRAIL for 24 h...

Synthetic Sphingosine 1-phosphate Receptor Modulators - Opportunities and Potential Pitfalls.

Sphingosine 1-phosphate (S1P) evokes a plethora of physiological responses by stimulating members of a G protein-coupled receptor family, known as S1P receptors. Currently five different mammalian S1P...

Clinical Trials [ 824 Associated Clinical Trials listed on BioPortfolio]

Evaluation of Chemotherapy Influence on Clinical and Biological Markers of Ovarian Reserve

The objective is to evaluate the influence of chemotherapy, either for auto-immune disease, either for carcinologic disease, on clinical and biological markers of ovarian reserve, for youn...

The Molecular Biology of Paroxysmal Nocturnal Hemoglobinuria (PNH)

This study is designed to better understand the molecular biology of paroxysmal nocturnal hemoglobinuria (PNH) and to determine if prion protein (PrP) functions in long term hematopoietic...

The Biology of Chronic Preconditioning: Genomic and Physiologic Mechanisms of Response

The purpose of this study is to assess the effects of repeated RIPC and exercise, on exercise performance, skeletal muscle responses and circulating cellular and humoral biology in humans

Brain, Biology and Mood Study

The purpose of the Brain, Biology and Mood study is to examine the association between stress, depression and cell death in the hippocampus. We fully expect this study to highlight compone...

A Clinical Trial Assessing Safety and Efficacy of BZL101 for Metastatic Breast Cancer

The investigators' proposed phase 2 clinical trial will be an open-label, non-randomized study among 80 women with metastatic breast cancer. The study treatment period will be up to twelve...

Companies [ 657 Associated Companies listed on BioPortfolio]

Receptor Biology Incorporated

Receptor Biology Inc. produce cloned receptors for pharmacology studies and drug discovery, products include adenosine, cannabinoid, dopamine, muscarinic, serotonin, opoid, bradykinin, transporter, wi...

Angstrom Pharmaceuticals Incorporated

Ångstrom Pharmaceuticals, Inc. was formed in 1996 to add a new dimension to drug discovery. It is committed to discovering drugs that block the docking of an extracellular regulatory protein (ligand)...

Aragon Pharmaceuticals Inc.

Aragon Pharmaceuticals is a privately held small-molecule drug discovery company identifying breakthrough medicines for the treatment of hormonally driven cancers. These cancers are traditionally trea...

Synaptic Pharmaceutical Corporation

Synaptic Pharmaceutical Corporation is a biotechnology company engaged in the development of a broad platform of enabling technology which it calls "human receptor- targeted drug design technology."...

Receptor BioLogix, Inc.

Receptor BioLogix, Inc. is a biopharmaceutical company focused on developing the first broad-spectrum anti-HER therapeutic, resulting from its program to commercialize a newly discovered class of prot...

More Information about "Receptor Biology Incorporated" on BioPortfolio

We have published hundreds of Receptor Biology Incorporated news stories on BioPortfolio along with dozens of Receptor Biology Incorporated Clinical Trials and PubMed Articles about Receptor Biology Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Receptor Biology Incorporated Companies in our database. You can also find out about relevant Receptor Biology Incorporated Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement